| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.13e-05 | 11 | 103 | 3 | GO:0005388 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 3.13e-05 | 2 | 105 | 2 | IPR013037 | |
| Domain | - | 3.13e-05 | 2 | 105 | 2 | 2.60.40.1150 | |
| Domain | ATPase_P-typ_TM_dom | 9.17e-05 | 16 | 105 | 3 | IPR023298 | |
| Domain | - | 9.17e-05 | 16 | 105 | 3 | 1.20.1110.10 | |
| Domain | AP_complex_bsu_1_2_4 | 9.36e-05 | 3 | 105 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 9.36e-05 | 3 | 105 | 2 | PF09066 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.11e-04 | 17 | 105 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.11e-04 | 17 | 105 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 1.32e-04 | 18 | 105 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.32e-04 | 18 | 105 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.57e-04 | 19 | 105 | 3 | IPR004014 | |
| Domain | B2-adapt-app_C | 1.86e-04 | 4 | 105 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 1.86e-04 | 4 | 105 | 2 | IPR015151 | |
| Domain | AP_beta | 3.10e-04 | 5 | 105 | 2 | IPR026739 | |
| Domain | Beta2_adaptin/TBP_C_dom | 4.63e-04 | 6 | 105 | 2 | IPR012295 | |
| Domain | - | 4.63e-04 | 6 | 105 | 2 | 3.30.310.10 | |
| Domain | ARM-type_fold | 6.57e-04 | 339 | 105 | 8 | IPR016024 | |
| Domain | Coatomer/calthrin_app_sub_C | 8.57e-04 | 8 | 105 | 2 | IPR009028 | |
| Domain | ATPase_P-typ_cyto_domN | 9.91e-04 | 35 | 105 | 3 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.08e-03 | 36 | 105 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 1.08e-03 | 36 | 105 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.08e-03 | 36 | 105 | 3 | PS00154 | |
| Domain | Alpha_adaptinC2 | 1.10e-03 | 9 | 105 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.10e-03 | 9 | 105 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.10e-03 | 9 | 105 | 2 | SM00809 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.17e-03 | 37 | 105 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.17e-03 | 37 | 105 | 3 | PF00122 | |
| Domain | Hydrolase_3 | 1.37e-03 | 10 | 105 | 2 | PF08282 | |
| Domain | WD40_repeat_dom | 1.45e-03 | 297 | 105 | 7 | IPR017986 | |
| Domain | ARM | 1.47e-03 | 40 | 105 | 3 | SM00185 | |
| Domain | Coatomer/clathrin_app_Ig-like | 1.99e-03 | 12 | 105 | 2 | IPR013041 | |
| Domain | fn3 | 2.22e-03 | 162 | 105 | 5 | PF00041 | |
| Domain | Armadillo | 2.34e-03 | 47 | 105 | 3 | IPR000225 | |
| Domain | PLAC | 2.73e-03 | 14 | 105 | 2 | PF08686 | |
| Domain | - | 2.75e-03 | 333 | 105 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.85e-03 | 335 | 105 | 7 | IPR015943 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.13e-03 | 15 | 105 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.13e-03 | 15 | 105 | 2 | PF01602 | |
| Domain | WD40 | 3.44e-03 | 259 | 105 | 6 | PF00400 | |
| Domain | WD40 | 4.07e-03 | 268 | 105 | 6 | SM00320 | |
| Domain | ARM-like | 4.21e-03 | 270 | 105 | 6 | IPR011989 | |
| Domain | WD40_repeat | 4.37e-03 | 272 | 105 | 6 | IPR001680 | |
| Domain | ig | 4.39e-03 | 190 | 105 | 5 | PF00047 | |
| Domain | Immunoglobulin | 4.39e-03 | 190 | 105 | 5 | IPR013151 | |
| Domain | UIM | 4.52e-03 | 18 | 105 | 2 | PF02809 | |
| Domain | WD_REPEATS_1 | 4.85e-03 | 278 | 105 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.94e-03 | 279 | 105 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.94e-03 | 279 | 105 | 6 | PS50294 | |
| Domain | PLAC | 5.03e-03 | 19 | 105 | 2 | PS50900 | |
| Domain | PLAC | 5.03e-03 | 19 | 105 | 2 | IPR010909 | |
| Domain | FN3 | 5.34e-03 | 199 | 105 | 5 | PS50853 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 2.70e-06 | 19 | 75 | 4 | MM1434 | |
| Pathway | BIOCARTA_MCALPAIN_PATHWAY | 2.70e-06 | 19 | 75 | 4 | M8719 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 1.11e-04 | 18 | 75 | 3 | M7552 | |
| Pathway | BIOCARTA_CARDIACEGF_PATHWAY | 1.11e-04 | 18 | 75 | 3 | MM1479 | |
| Pubmed | DUSP28 RELA CEMIP2 PPP1R3D CCT5 PTPRM NUFIP2 SEC16A PUS1 CCAR2 HERC1 CDC25C ZNF512 ATP2A2 KPNA1 SYMPK HDLBP FBXW7 | 5.40e-09 | 1049 | 110 | 18 | 27880917 | |
| Pubmed | CAPN1 THOC2 DHX30 AP1B1 AP2B1 CCT5 TLN1 NUFIP2 SEC16A CCAR2 ZNF512 ATP2A2 SYMPK HDLBP | 2.07e-08 | 653 | 110 | 14 | 22586326 | |
| Pubmed | SYNE1 NFASC ZNFX1 WDR37 ARCN1 PDXK EPN2 DHX30 AP1B1 AP2B1 CCT5 TLN1 NUFIP2 SEC16A SIPA1L2 ATP2A2 ATP2B2 HDLBP | 5.64e-07 | 1431 | 110 | 18 | 37142655 | |
| Pubmed | ZNF536 IFT172 SYNE1 DOCK10 DHX30 TLN1 NUFIP2 SEC16A CCAR2 SIPA1L2 | 7.15e-07 | 407 | 110 | 10 | 12693553 | |
| Pubmed | IFT172 THOC2 ARCN1 DHX30 AP1B1 AP2B1 CCT5 TLN1 CCAR2 TRMT1L ATP2A2 SYMPK | 8.98e-07 | 638 | 110 | 12 | 33239621 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DUSP28 IFT172 LSR AP1B1 AP2B1 CCT5 PTPRM CIBAR1 SEC16A PUS1 CCAR2 SIPA1L2 CDC25C KPNA1 | 2.53e-06 | 974 | 110 | 14 | 28675297 |
| Pubmed | ZNF536 KMT2B RELA MIER1 DHX30 CCT5 ZBTB21 SEC16A CCAR2 ELF2 TRMT1L HERC1 CLP1 ZNF512 ATP2A2 SYMPK FBXW7 | 2.56e-06 | 1429 | 110 | 17 | 35140242 | |
| Pubmed | KMT2B FLYWCH1 SYNE1 RELA EPN2 DHX30 LSR CCT5 PIK3C2A INTS13 TLN1 NUFIP2 TRMT1L CLP1 ATP2A2 KPNA1 HDLBP | 4.75e-06 | 1497 | 110 | 17 | 31527615 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAPN1 DOCK10 ARCN1 DHX30 CDC40 AP2B1 CCT5 PIK3C2A TLN1 SEC16A ANKIB1 CCAR2 ZNF512 ATP2A2 KPNA1 HDLBP | 5.62e-06 | 1353 | 110 | 16 | 29467282 |
| Pubmed | 9.02e-06 | 230 | 110 | 7 | 35449600 | ||
| Pubmed | CAPN1 THOC2 ARCN1 DHX30 GSPT2 AP2B1 CCT5 PIK3C2A TLN1 NUFIP2 SEC16A HRAS TRMT1L ATP2A2 HDLBP | 9.28e-06 | 1247 | 110 | 15 | 27684187 | |
| Pubmed | Investigating a downstream gene of Gpnmb using the systems genetics method. | 9.91e-06 | 2 | 110 | 2 | 31057322 | |
| Pubmed | Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors. | 9.91e-06 | 2 | 110 | 2 | 19420964 | |
| Pubmed | Burn wounds in the young versus the aged patient display differential immunological responses. | 9.91e-06 | 2 | 110 | 2 | 29895402 | |
| Pubmed | Epidermal growth factor activates m-calpain, resulting in apoptosis of HaCaT keratinocytes. | 9.91e-06 | 2 | 110 | 2 | 15488707 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18071073 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.14e-05 | 333 | 110 | 8 | 32665550 | |
| Pubmed | 1.36e-05 | 15 | 110 | 3 | 37392737 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CAPN1 RELA WNK1 ARCN1 GSPT2 AP1B1 AP2B1 CCT5 INTS13 TLN1 SEC16A PUS1 CCAR2 HERC1 KPNA1 HDLBP | 1.39e-05 | 1455 | 110 | 16 | 22863883 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MIX23 HKDC1 THOC2 WNK1 ARCN1 MRPL18 AP1B1 AP2B1 CCT5 TLN1 CCAR2 KPNA1 | 1.60e-05 | 847 | 110 | 12 | 35235311 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.67e-05 | 582 | 110 | 10 | 20467437 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.69e-05 | 462 | 110 | 9 | 31138677 | |
| Pubmed | 2.38e-05 | 107 | 110 | 5 | 30995489 | ||
| Pubmed | 2.43e-05 | 18 | 110 | 3 | 10567358 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 2.43e-05 | 370 | 110 | 8 | 22922362 | |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 2.65e-05 | 272 | 110 | 7 | 18187620 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25661196 | ||
| Pubmed | Growth factors upregulate astrocyte [Ca2+]i oscillation by increasing SERCA2b expression. | 2.97e-05 | 3 | 110 | 2 | 20878766 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 31676369 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 27230679 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28772241 | ||
| Pubmed | Ras activity regulates cyclin E degradation by the Fbw7 pathway. | 2.97e-05 | 3 | 110 | 2 | 15980150 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 22797700 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 37038032 | ||
| Pubmed | IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity. | 2.97e-05 | 3 | 110 | 2 | 20428758 | |
| Pubmed | 4.03e-05 | 60 | 110 | 4 | 34761192 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | THOC2 WNK1 ARCN1 DHX30 AP2B1 TLN1 NUFIP2 ZBTB21 SEC16A ELF2 SIPA1L2 HDLBP | 4.14e-05 | 934 | 110 | 12 | 33916271 |
| Pubmed | Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain. | 4.54e-05 | 22 | 110 | 3 | 26950368 | |
| Pubmed | 4.74e-05 | 298 | 110 | 7 | 30737378 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2B OBSCN WNK1 DHX30 TRAPPC12 TLN1 SEC16A GPC2 HERC1 SIPA1L2 SOWAHB EVI5L SYMPK | 4.81e-05 | 1105 | 110 | 13 | 35748872 |
| Pubmed | ZNF536 SKIL WDR37 ZC3H3 PSMG3-AS1 ZNF610 INTS13 CIBAR1 ZBTB21 SEC16A SIPA1L2 EVI5L KPNA1 | 5.32e-05 | 1116 | 110 | 13 | 31753913 | |
| Pubmed | 5.61e-05 | 128 | 110 | 5 | 30995482 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 7534311 | ||
| Pubmed | Role of activation of PIP5Kgamma661 by AP-2 complex in synaptic vesicle endocytosis. | 5.92e-05 | 4 | 110 | 2 | 17290217 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 31787981 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 28844984 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 9707615 | ||
| Pubmed | Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. | 5.94e-05 | 24 | 110 | 3 | 20705733 | |
| Pubmed | 6.03e-05 | 421 | 110 | 8 | 36976175 | ||
| Pubmed | 6.45e-05 | 549 | 110 | 9 | 38280479 | ||
| Pubmed | 6.73e-05 | 25 | 110 | 3 | 38877142 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 6.84e-05 | 316 | 110 | 7 | 31665637 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ARCN1 AP1B1 AP2B1 CCT5 TLN1 NUFIP2 SEC16A CCAR2 TRMT1L ATP2A2 KPNA1 SYMPK HDLBP | 7.14e-05 | 1149 | 110 | 13 | 35446349 |
| Pubmed | 7.59e-05 | 26 | 110 | 3 | 24067654 | ||
| Pubmed | 7.99e-05 | 223 | 110 | 6 | 33731348 | ||
| Pubmed | 8.39e-05 | 225 | 110 | 6 | 12168954 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 8.93e-05 | 573 | 110 | 9 | 28330616 | |
| Pubmed | 8.99e-05 | 446 | 110 | 8 | 24255178 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 21444916 | ||
| Pubmed | Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. | 9.85e-05 | 5 | 110 | 2 | 20406971 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 12823437 | ||
| Pubmed | The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits. | 9.85e-05 | 5 | 110 | 2 | 26269414 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 9266971 | ||
| Pubmed | Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7. | 9.85e-05 | 5 | 110 | 2 | 20208556 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 16723738 | ||
| Pubmed | Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis. | 9.85e-05 | 5 | 110 | 2 | 25361978 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SYNE1 THOC2 ARCN1 DHX30 LSR CCT5 TLN1 ZBTB21 SEC16A CCAR2 ATP2A2 HDLBP | 9.92e-05 | 1024 | 110 | 12 | 24711643 |
| Pubmed | 1.06e-04 | 29 | 110 | 3 | 15071553 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | CAPN1 RELA WNK1 ARCN1 AP1B1 CCT5 PIK3C2A MARCHF5 TLN1 SEC16A GPNMB ATP2A2 SYMPK HDLBP | 1.07e-04 | 1367 | 110 | 14 | 32687490 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ZNFX1 RELA WNK1 ARCN1 PPP1R3D AP1B1 AP2B1 SEC16A CCAR2 CNOT4 EVI5L SAMD4A | 1.13e-04 | 1038 | 110 | 12 | 26673895 |
| Pubmed | 1.13e-04 | 591 | 110 | 9 | 15231748 | ||
| Pubmed | 1.30e-04 | 153 | 110 | 5 | 10718198 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.43e-04 | 477 | 110 | 8 | 31300519 | |
| Pubmed | DBF4B SYNE1 BBS2 C1orf167 ZNF610 CCT5 NUFIP2 SEC16A KPNA1 HDLBP | 1.44e-04 | 754 | 110 | 10 | 35906200 | |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 30865892 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 11389730 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 31802034 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 10966473 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 29135520 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.47e-04 | 6 | 110 | 2 | 12767889 | |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 22964303 | ||
| Pubmed | Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. | 1.47e-04 | 6 | 110 | 2 | 19197368 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | WNK1 ARCN1 DHX30 GSPT2 AP1B1 AP2B1 CCT5 TLN1 SEC16A CCAR2 TRMT1L ATP2A2 KPNA1 HDLBP | 1.53e-04 | 1415 | 110 | 14 | 28515276 |
| Pubmed | 1.57e-04 | 33 | 110 | 3 | 26025364 | ||
| Pubmed | 1.59e-04 | 253 | 110 | 6 | 29911972 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MARS2 SYNE1 THOC2 ARCN1 PDXK DHX30 CDC40 CCT5 TLN1 PUS1 CCAR2 ZNF512 ATP2A2 HDLBP | 1.65e-04 | 1425 | 110 | 14 | 30948266 |
| Pubmed | 1.66e-04 | 255 | 110 | 6 | 15324660 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.70e-04 | 162 | 110 | 5 | 14743216 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B THOC2 MIER1 ZBTB21 SEC16A CCAR2 ELF2 ATP2A2 SYMPK HDLBP | 1.78e-04 | 774 | 110 | 10 | 15302935 |
| Pubmed | ARCN1 DHX30 AP1B1 TLN1 SEC16A CCAR2 ZNF512 ATP2A2 SYMPK HDLBP | 2.02e-04 | 786 | 110 | 10 | 29128334 | |
| Pubmed | GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment. | 2.06e-04 | 7 | 110 | 2 | 21454528 | |
| Pubmed | IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. | 2.06e-04 | 7 | 110 | 2 | 15858576 | |
| Pubmed | 2.06e-04 | 7 | 110 | 2 | 7690439 | ||
| Pubmed | Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. | 2.06e-04 | 7 | 110 | 2 | 19651702 | |
| Pubmed | 2.08e-04 | 266 | 110 | 6 | 19380743 | ||
| Pubmed | 2.16e-04 | 645 | 110 | 9 | 25281560 | ||
| Pubmed | 2.37e-04 | 653 | 110 | 9 | 33742100 | ||
| Pubmed | 2.42e-04 | 95 | 110 | 4 | 29490077 | ||
| Pubmed | SYNE1 NFASC ZNFX1 AP1B1 AP2B1 NUFIP2 ZBTB21 SEC16A HRAS CCAR2 KPNA1 | 2.44e-04 | 963 | 110 | 11 | 28671696 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.49e-04 | 807 | 110 | 10 | 30575818 | |
| Interaction | CLTB interactions | 5.66e-06 | 185 | 105 | 8 | int:CLTB | |
| Interaction | PPEF1 interactions | 7.46e-06 | 52 | 105 | 5 | int:PPEF1 | |
| Interaction | WNK3 interactions | 1.08e-05 | 56 | 105 | 5 | int:WNK3 | |
| Interaction | ARHGAP18 interactions | 3.08e-05 | 115 | 105 | 6 | int:ARHGAP18 | |
| Interaction | SIRT7 interactions | CAPN1 THOC2 DHX30 AP1B1 AP2B1 CCT5 TLN1 NUFIP2 SEC16A CCAR2 ZNF512 ATP2A2 SYMPK HDLBP | 3.16e-05 | 744 | 105 | 14 | int:SIRT7 |
| Cytoband | 17q11.2-q12 | 1.19e-04 | 7 | 110 | 2 | 17q11.2-q12 | |
| GeneFamily | ATPases Ca2+ transporting | 5.43e-06 | 9 | 74 | 3 | 1209 | |
| GeneFamily | ADAMTS like | 3.42e-04 | 7 | 74 | 2 | 947 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.17e-04 | 161 | 74 | 5 | 593 | |
| GeneFamily | WD repeat domain containing | 7.11e-04 | 262 | 74 | 6 | 362 | |
| GeneFamily | Immunoglobulin like domain containing | 1.17e-03 | 193 | 74 | 5 | 594 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 3.30e-03 | 21 | 74 | 2 | 980 | |
| GeneFamily | Fibronectin type III domain containing | 4.20e-03 | 160 | 74 | 4 | 555 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-07 | 190 | 110 | 7 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-07 | 190 | 110 | 7 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.34e-06 | 188 | 110 | 6 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.53e-06 | 193 | 110 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 119 | 110 | 5 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 3.79e-05 | 152 | 110 | 5 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-05 | 154 | 110 | 5 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 172 | 110 | 5 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.35e-05 | 90 | 110 | 4 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.35e-05 | 90 | 110 | 4 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 177 | 110 | 5 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-05 | 177 | 110 | 5 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 7.81e-05 | 177 | 110 | 5 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 177 | 110 | 5 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.02e-05 | 178 | 110 | 5 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.90e-05 | 182 | 110 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-05 | 182 | 110 | 5 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-05 | 183 | 110 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.61e-05 | 185 | 110 | 5 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.61e-05 | 185 | 110 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.86e-05 | 186 | 110 | 5 | 310d16f4e5cffee3ea6d7635508c513a3b92131e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 187 | 110 | 5 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 187 | 110 | 5 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 187 | 110 | 5 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-04 | 187 | 110 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 187 | 110 | 5 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 188 | 110 | 5 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 188 | 110 | 5 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 188 | 110 | 5 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 188 | 110 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.06e-04 | 189 | 110 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 110 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-04 | 189 | 110 | 5 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.06e-04 | 189 | 110 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.09e-04 | 190 | 110 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 190 | 110 | 5 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.09e-04 | 190 | 110 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.12e-04 | 191 | 110 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 191 | 110 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 191 | 110 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-04 | 191 | 110 | 5 | a53616c84178eb6c29b48662358765b082df3f97 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Tem/emra_CD8|bone_marrow / Manually curated celltypes from each tissue | 1.12e-04 | 191 | 110 | 5 | db7b8f8826bf19d6eeee14319570a9e6e99ab2cb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-04 | 191 | 110 | 5 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 192 | 110 | 5 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-04 | 192 | 110 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 192 | 110 | 5 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 192 | 110 | 5 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 192 | 110 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 193 | 110 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 193 | 110 | 5 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 193 | 110 | 5 | 6a9bce5064938b5b84ad57b4fd4a7841afe100c8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 193 | 110 | 5 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.17e-04 | 193 | 110 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 193 | 110 | 5 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 194 | 110 | 5 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.20e-04 | 194 | 110 | 5 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.20e-04 | 194 | 110 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 194 | 110 | 5 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 194 | 110 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 194 | 110 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.26e-04 | 196 | 110 | 5 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.26e-04 | 196 | 110 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.29e-04 | 197 | 110 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | Control-Myeloid-TRAM3|Control / Disease group,lineage and cell class (2021.01.30) | 1.29e-04 | 197 | 110 | 5 | 733ff40039d67e561c2ded7c9bd0b4353101741e | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 197 | 110 | 5 | 6ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-04 | 197 | 110 | 5 | 4416efdbd9c4ac3356a5dff2d535c2d7383376a9 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 197 | 110 | 5 | 0f1c4a328968b32874e6ebb0803e665adcbbc450 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-04 | 197 | 110 | 5 | aafe0cd697b0b7f0756596148e0906443fdf8ef7 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 197 | 110 | 5 | ca6bce1a92c6326f41a6300c31da02386bafa152 | |
| ToppCell | BAL-Control-Myeloid-TRAM-TRAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-04 | 197 | 110 | 5 | e131634bc67e0bd31a938a8e8df8dc752e1d0f47 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 197 | 110 | 5 | e3be7758a92f12e0a423394822957e1b7f995110 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.35e-04 | 199 | 110 | 5 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 199 | 110 | 5 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 200 | 110 | 5 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Mesoderm|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-04 | 200 | 110 | 5 | 9ef226ebb0a7cdb9431e2fa65faa2a7d67da590d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 200 | 110 | 5 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 200 | 110 | 5 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 200 | 110 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-04 | 200 | 110 | 5 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 200 | 110 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-OPRM1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 559cf4001a3f985c8357f0102b34fab2e34d2a04 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-04 | 200 | 110 | 5 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 200 | 110 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 200 | 110 | 5 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.38e-04 | 200 | 110 | 5 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 200 | 110 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.98e-07 | 199 | 109 | 9 | 4523_DN | |
| Disease | Hearing abnormality | 7.78e-05 | 4 | 107 | 2 | C4025860 | |
| Disease | tyrosine-protein kinase TEC measurement | 7.78e-05 | 4 | 107 | 2 | EFO_0020830 | |
| Disease | Malignant neoplasm of breast | SYNE1 OBSCN RELA WNK1 EGF CCT5 TRAPPC12 HRAS PUS1 GPNMB GPC2 HDLBP FBXW7 | 1.40e-04 | 1074 | 107 | 13 | C0006142 |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.94e-04 | 6 | 107 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Alveolitis, Fibrosing | 2.41e-04 | 83 | 107 | 4 | C4721507 | |
| Disease | Pulmonary Fibrosis | 2.64e-04 | 85 | 107 | 4 | C0034069 | |
| Disease | heart disease (implicated_via_orthology) | 3.57e-04 | 38 | 107 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 3.60e-04 | 8 | 107 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | myositis | 3.85e-04 | 39 | 107 | 3 | EFO_0000783 | |
| Disease | Secondary Biliary Cholangitis | 4.80e-04 | 42 | 107 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 4.80e-04 | 42 | 107 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 4.80e-04 | 42 | 107 | 3 | C4551595 | |
| Disease | Neoplasm Invasiveness | 5.68e-04 | 184 | 107 | 5 | C0027626 | |
| Disease | Primary biliary cirrhosis | 6.69e-04 | 47 | 107 | 3 | C0008312 | |
| Disease | monocyte count | ARHGAP42 MARS2 DOCK10 ACVRL1 WNK1 MIER1 ARCN1 KITLG EGF MARCHF5 TLN1 NUFIP2 DISP1 | 9.89e-04 | 1320 | 107 | 13 | EFO_0005091 |
| Disease | response to efavirenz, virologic response measurement | 1.24e-03 | 58 | 107 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | creatine kinase measurement | 1.30e-03 | 59 | 107 | 3 | EFO_0004534 | |
| Disease | Neoplasms, Experimental | 1.80e-03 | 66 | 107 | 3 | C0027659 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 1.92e-03 | 18 | 107 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.92e-03 | 18 | 107 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Malignant Glioma | 2.13e-03 | 70 | 107 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.13e-03 | 70 | 107 | 3 | C0259783 | |
| Disease | cystathionine measurement | 2.14e-03 | 19 | 107 | 2 | EFO_0010474 | |
| Disease | epilepsy (biomarker_via_orthology) | 2.62e-03 | 21 | 107 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 3.06e-03 | 525 | 107 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.06e-03 | 525 | 107 | 7 | C1257931 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.11e-03 | 80 | 107 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Disease Exacerbation | 3.11e-03 | 165 | 107 | 4 | C0235874 | |
| Disease | Mammary Neoplasms | 3.13e-03 | 527 | 107 | 7 | C1458155 | |
| Disease | Breast Carcinoma | 3.50e-03 | 538 | 107 | 7 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INVFTTIKQGSRCDR | 96 | Q8N2C9 | |
| VRTAIRCAQAQTGID | 381 | Q8N163 | |
| KRELAVVRQQCSSAA | 416 | Q96CN4 | |
| TQLSLCRQKAGREAV | 736 | Q5SNV9 | |
| AIGRCAIKVEQSAER | 376 | P63010 | |
| TCGGVRNVSVETRNV | 11 | Q6ZS02 | |
| KLGRCSVRVSVNTAN | 186 | Q14956 | |
| TVQVALDKAREGRTC | 1256 | O95342 | |
| GCDRAVRLTKQGSNT | 426 | Q9P2G1 | |
| RTVARQVALVECVGK | 196 | P37023 | |
| CKVNDVEAIRSQGLA | 321 | Q3MIX3 | |
| AIGRCAIKVEQSAER | 376 | Q10567 | |
| NNSCSGRVEVKFQER | 161 | Q9NR16 | |
| CTGVSAQVQKQRARE | 11 | P07384 | |
| VTEGRGARCNVIITQ | 476 | Q7L2E3 | |
| QSCGRIVRVKCNSVD | 1481 | Q96F81 | |
| ARAGVTLCVNVSRQQ | 41 | Q4G0W2 | |
| TGDNINTARAIAIKC | 731 | Q01814 | |
| VEAGCVANNAVIRKN | 436 | O75185 | |
| SDCTGSRLRNVKVQT | 581 | Q9Y2G4 | |
| NKCDLAARTVESRQA | 116 | P01112 | |
| GDRVINTNCSAVRTR | 106 | Q9Y644 | |
| NRGRIICITNAKSDS | 156 | Q9NVM9 | |
| VTSRAKERQENGAVV | 516 | Q8IYY4 | |
| CRVIALRSVKNGAET | 13976 | Q8WXI7 | |
| VSEKAANIARACRQQ | 11 | P49441 | |
| ECVAQNRFGLVVSRK | 116 | Q8IVU1 | |
| GQSLCRTVKESEAQR | 201 | Q96PY0 | |
| AKVTRSCAETRQVLG | 26 | Q8N158 | |
| KTGSERVAQQCRENI | 86 | O95208 | |
| GCRSRAITQGQRVTV | 311 | Q4VC44 | |
| SSNCVRKVAERLDQG | 541 | A9Z1Z3 | |
| VGVAACSNRSKDVLV | 3801 | Q15751 | |
| VKQDQVCIARLRTAG | 576 | Q8IYD1 | |
| VTAQRNICGENASVK | 411 | O00443 | |
| VDEKQRGNSTARVAC | 51 | Q9NX47 | |
| CRRKQQAVVVAEAAV | 231 | Q9UMN6 | |
| CFRQSTAKIQIVRGG | 381 | P29728 | |
| ATVICRKNASISVRA | 296 | P29460 | |
| RCRSQSKVQEGERQL | 446 | P30307 | |
| SRGARVVSNDNKECL | 61 | Q9Y5F1 | |
| GSAQIRQVRVQESSC | 2026 | Q7Z442 | |
| ATNSIVAAGCDRKIV | 206 | Q9UG01 | |
| TGCTRRLVVQQAGQA | 941 | Q5VST9 | |
| EAVGCTRRLVVQQAG | 1491 | Q5VST9 | |
| RGVLECQVSRASAQV | 2306 | Q5VST9 | |
| CVATNILGKAENQVR | 501 | O94856 | |
| VASSVKLCRQAGIRV | 606 | P16615 | |
| KNQVITACRDAIRSN | 691 | Q9BXC9 | |
| LDSCTGVVQNNRLRK | 241 | Q96BY6 | |
| GTGQVSTCRLRKDQQ | 256 | A1XBS5 | |
| SRQERVCNIEKNVSG | 106 | P01133 | |
| RIRKEDSCQASVTQG | 386 | Q8NFT6 | |
| RASNTKLVCAVGSRN | 676 | Q969H0 | |
| SQGCERVKIQAATDS | 1146 | Q9UHN6 | |
| AVVFVTRKNRQVCAN | 61 | P13501 | |
| INCSRAEKGVARVVN | 346 | Q15723 | |
| AAVCTKAGKAIVSRQ | 6 | P48444 | |
| QSSRRAVEDQLKICG | 26 | A6NJI9 | |
| CQDSVRTVRVVATKQ | 166 | Q86X29 | |
| RTVRVVATKQGNAVT | 171 | Q86X29 | |
| QANKVRTRSVGECVA | 311 | Q8N108 | |
| SRANGETKIDCVQVA | 706 | P28827 | |
| RVTECGIRAKAVSQD | 76 | Q9HBJ0 | |
| RRSGKTQQEASRVCV | 51 | Q8TDW5 | |
| VAAVARAAARCNKGI | 436 | Q7Z2T5 | |
| ESATCNLVRDINKVG | 491 | P12757 | |
| ARKVVNRDSCVQEAA | 1616 | Q8NF91 | |
| AARNCLVSEAGVVKV | 491 | P42680 | |
| IVVKEVCGAVSRRAA | 816 | Q2TB90 | |
| NFVRKCIQAVETRGI | 396 | A6NI28 | |
| RCARTDKGVSAAGQV | 141 | Q9Y606 | |
| NDKIQAVIDAGVCRR | 286 | P52294 | |
| TETGQCISRFTNRKV | 361 | O60508 | |
| CRSTVKVSAQQVQGV | 116 | Q13103 | |
| RQGSRLVEICKVAVA | 986 | Q9P2F8 | |
| QCKNSRAVTIFIRGG | 376 | P48643 | |
| EGICRNRVTNNVKDV | 26 | P21583 | |
| AQARASCAAAKTQGR | 181 | A6NEL2 | |
| VLQRTIQCAKAQAGE | 266 | O00764 | |
| VFGDNESQATIRVKC | 231 | P0CW24 | |
| IRVKCLTAQQQSGER | 241 | P0CW24 | |
| KSRVAAQNSAEVVRC | 31 | P52823 | |
| EVNRRASVSGCVINT | 216 | Q92989 | |
| RAIQCVNNVVVDGRT | 171 | O95628 | |
| IVKNTDGRECVRSVN | 91 | Q8N9Z0 | |
| KRSVIVCQSRNEAQG | 146 | Q9ULJ3 | |
| QAREASLVVTCRTNK | 291 | Q8IXZ2 | |
| RERSQCGVKAVNKAS | 1231 | Q8NI27 | |
| IVRRTSKEACQQAGC | 246 | P60852 | |
| SRDRVIKNCIAQTSA | 66 | Q4VC31 | |
| ARRNSAKGCENLNIV | 226 | Q7Z417 | |
| VVGEVRETCVRQKQC | 631 | O15027 | |
| RAVATQQRGAVFVDK | 321 | Q8WVT3 | |
| RLVAKAVEGCVSASQ | 741 | Q9Y490 | |
| NVVACESIGRVLAQR | 121 | Q9H0U6 | |
| GTVRVCNVAFEKQVA | 191 | O95685 | |
| GDKNSINCARQEAIR | 836 | O00507 | |
| KALEAVSSCVRQTNG | 471 | Q96GW9 | |
| RAEKAVACSGAAQVR | 571 | Q92797 | |
| NCQKTSIVRVGGRSN | 671 | Q9P2E3 | |
| GVTVNCKDQAREASK | 1036 | O15090 | |
| RTDSAINRINVCVGQ | 406 | Q9Y2I8 | |
| AARTVKCVNRNLTEV | 71 | Q13641 | |
| TIIITGKRANCEAAR | 626 | Q00341 | |
| AGSCALRNRTADQKV | 356 | A2RRH5 | |
| RILNVSNKGDRVVEC | 1121 | Q9H4A3 | |
| QRTRDVKCVSNIGDV | 756 | Q6ZMP0 | |
| GTQQREVICVRKNAD | 871 | Q6ZMP0 | |
| TAELKICRVNRNSGS | 191 | Q04206 | |
| RSTRIVGAKNSRTQC | 21 | Q96ME7 | |
| TECQLEAQNVTKGAR | 356 | Q9UPU9 | |
| VTAGGRVTLQCQKRD | 136 | B6A8C7 | |
| RQVTCKRTKANGTVQ | 1506 | P82987 |